CANCER (Grape diet)

April 11, 2000

In a message dated 4/11/00 6:19:50 PM Eastern Daylight Time,

sandra@... writes:

<< Thanks everyone for all your input - we are looking into the Gerson Therapy

for my friend who has just been diagnosed with Lung Cancer.........just

had her first blast of radium (4days consecutively).

If any one knows about thisor Beata Bishop whereabouts re tThe Grape

Diet.............please get in touch quickly - time is short .

Many thanks

*************************************************************************

,

I am a holistic healer and a holistic researcher of fibromyaliga

and chronic fatique syndrome, and I am very familar with the

grape diet.

The grape diet works because the grapes have ellagic acid in them.

The Hollings Cancer Institute at the Medical University of South

Carolina is doing a hugh clinical study on ellagic acid that is 7 times

stronger than grapes from the seeds of the Washington Meeger red

raspberry. Moreover, they are having incredible results. The

product in question has been clinically proven to cause G-arrest

(stop cell mitosis-splitting and duplication) with 48 hours, and

cause apoptosis (a natural cell death within 72 hours)

Here is the information and let me know ASAP if you need access to the

same product that the cancer institute is testing.

Sincerely,

Steve Podhouser

healerstouch1@...

To all Oncologist's:

The Hollings Cancer instititute at the University of South Carolina

is doing a double blind study on a large group of 500 cervical cancer

patients that has everyone excited. They are excited because

their past nine years of study have shown that a natural product

called ellagic acid is causing G-arrest within 48 hours (inhibiting and

stopping mitosis-cancer cell division), and apoptosis (normal cell

death) within 72 hours, for breast, pancreas, esophageal, skin, colon

and prostate cancer cells. Clinical tests also show that ellagic

acid prevents the destruction of the p53 gene by cancer cells.

Additional studies suggest that one of the mechanisms by which

ellagic acid inhibits mutagenesis and carcinogenesis is by forming

adducts with DNA, thus masking binding sites to be occupied by the

mutagen or carcinogen.

Ellagic acid can be found in different foods, but the clinic has identified

the red raspberry as having the highest content of the acid. Moreover, the

doctors at Holling's have created a patent pending process of extracting

potent levels of the acid from the seeds of the raspberrys that are getting

dramatic results. Other USA sources substantiate the Hollings

Cancer Institute include:

Department of Surgical Oncology, College of Medicine, University of

Illinois at Chicago, Illinois; Division of Environmental Health Sciences,

The Ohio State University School of Public Health, Colombus, Ohio;

Departmant of Medicine, Lakeside Veterans Affairs Medical Center,

Northwestern University School of Medicine, Stanford, CA; Department

of Preventative Medicine, Ohio State University, Colombus, Ohio.

Here is a description of the study which came from a website of the

Washington Raspberry Commission. You can see the Hollings research

articles there.

http://www.red-raspberry.com/

Here are some notes from the site. Reprinted by permission from WRC

" The proposed study, under the direction of Nixon, M.D., President of

the American Health Foundation and Drs. Dave Gangemi and Blair Holliday of

the Hollings Cancer Center/Medical University of South Carolina, will

evaluate women with atypical squamous cells of undetermined significance

(ASCUS) in which there is neither treatment nor clinical evaluation

available. ASCUS represents as much as 10% of all Papanicolaou smears in the

US and represents approximately 5 million females. In this population, these

women who are infected with human papillomaviruses (HPV) types 16 and/or 18

are at the greatest risk of developing cervical cancer at some stage in their

lives. In addition, women who are diagnosed with the immature metaplastic

form of ASCUS usually have lesions which are higher in the endocervical

canal, are more metabolically active, have flatter surface areas, and are

more likely to invade the underlying connective tissue as well as the

endocervical glandular epithelium. This population represents approximately

one million women in the United States alone. The condition is very

pronounced in countries outside the United States. In India this is one of

the two major cancers affecting women. "

Research sources:

Cancer Lett 1999 Mar 1 1;136(2):215-21

Expression and its posssible role in G1 arrest and apoptosisi in ellagic

acid treated cancer cells.

Narayanan BA, Geoffroy O, Wilmington MC, Re GG, Nixon DWCANCER P

Prevention program, Hollings Cancer Center, Medical University of South

Carolina, ton 29425, USA.

" Ellagia acid is a phenolic compound present in fruits and nuts including

raspberries, strawberries and walnuts. It is known to inhibit certain

carcinogen-induced cancers and may have other chemopreventive

properties. The effects of ellagic acid on cell cycle events and apoptosis

were studied in cervical carcinoma (CaSki) cells. We found that ellagic

acid at a concentration of 10(-5) M induced G arrest within 48 h, inhibited

overall cell growth and induced apoptosis in CaSki cells after 72 h of

treatment. Activation of the cdk inhibitory protein p21 by ellagic acid

suggests a role for ellagic acin in cell cycle regulation of cancer cells. "

Focus: To Evaluate Red Raspberry Ellagic Acid in Prevention of Cervical Cancer

There is now clinical evidence to suggest that ellagic acid concentrations at

tissue sites such as the cervix may be obtained with the oral administration

of red raspberries. This belief comes from bioavailability studies in which

human volunteers have ingested raspberry puree. Because of this and

observations in human volunteers ingesting daily quantities of raspberry

puree for prevention of colon cancer, a clinical trial will examine ellagic

acid from raspberries in prevention of pre-cancerous cervical lesions

developing into a malignant condition.

The proposed study, under the direction of Nixon, M.D., President of